Plain-English translation of NCT06590506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows patients with advanced cancer who are starting their first treatment. Researchers want to understand why some patients respond well to treatment while others don't, and what personal health factors might influence this. To do this, they'll collect detailed information from you—including data from a wearable device, questionnaires, and medical details—to build a large picture of how different people with cancer respond to their chosen treatment.
Doctors know that cancer patients respond to treatment very differently from one another, but they don't fully understand why. By studying many patients carefully from the start of their treatment, researchers hope to discover which personal health factors matter most for how well treatment works and how well patients tolerate it.
You likely qualify if…
You likely don't qualify if…
You will wear a health-monitoring device that tracks your body's data while you receive your regular cancer treatment as planned. Throughout your treatment, you'll complete online questionnaires about your quality of life, nutrition, and mental health. The research team will follow your medical progress, collect information about how your body responds to treatment, and use this data along with information from other participants to identify patterns about what helps people tolerate and respond well to cancer treatment.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Spain